← SynDRA
LDC1267
SynDRA canonical compound SYN1956934 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | AURKB | AXL | MERTK | MET | TYRO3 |
|---|
| Mechanism of action | protein tyrosine kinase inhibitor |
|---|
All known targets
- AXL
- MERTK
- TYRO3
- AURKB
- MET
Mechanisms of action (all sources)
- tyrosine kinase inhibitor
- AXL INHIBITOR
- TYRO3 INHIBITOR
- MERTK INHIBITOR
Cross-references
Synonyms
- LDC-1267
- CHEMBL3808844
- SCHEMBL167963
- GTPL8247
- MolPort-035-944-330
- EX-A2265
- AOB87188
- BCP14023
- BDBM50172075
- s7638
- ZINC113241878
- AKOS026750422
- CS-3603
- SB19391
- NCGC00386431-02
- HY-12494
- N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluoro-2-methylphenyl)-1H-pyrazole-3-carboxamide
Look up LDC1267 in the interactive SynDRA portal →